Pathological τ proteins in postencephalitic Parkinsonism: Comparison with Alzheimer's disease and other neurodegenerative disorders

Annals of Neurology

Volumn 42, Issue 3, 1997, Pages 356-359

  Buée Scherrer, Valérie ^a,d,g   Buée, Luc ^a,b   Leveugle, Béatrice ^c   Perl, Daniel P ^b,c   Vermersch, Patrick ^b,c   Hof, Patrick R ^c,d,e   Delacourte, André ^c,f  

^a INSERM   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d Neurobiology of Aging Laboratories   (United States)

^e UNIVERSITY OF ALBERTA   (Canada)

^f MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^g MRC ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

TAU PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN DEGENERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; NEOCORTEX; NEUROFIBRILLARY TANGLE; PARKINSON DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN PHOSPHORYLATION;

AGED; ALZHEIMER DISEASE; ENCEPHALITIS; HIPPOCAMPUS; HUMANS; MOTOR CORTEX; NEUROFIBRILLARY TANGLES; PARKINSON DISEASE; SUPRANUCLEAR PALSY, PROGRESSIVE; TAU PROTEINS;

EID: 0039707140     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410420312     Document Type: Article

References (19)

1. Hof PR, Morrison JH. The cellular basis of cortical disconnection in Alzheimer's disease and related dementing conditions. In: Terry RD, Katzman R, Bick KL, eds. Alzheimer's disease. New York: Raven Press, 1994:197-229
2. Delacourte A, Flament S, Dibe EM, et al. Pathological tau proteins tau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's disease. Demonstration with a panel of antibodies against tau proteins. Acta Neuropathol 1990:80:111-119
3. Goederr M, Spillantini MG, Cairns NJ, Crowther RA. Tau proteins of Alzheimer paired helical filaments-abnormal phosphorylation of all six brain isoforms. Neuron 1992;8:159-168
4. Sergeant N, Bussiere T, Vermersch P, et al. Isoelectric point differentiates PHF-tau from biopsy-derived human brain tau proteins. Neuroreport 1995;6:2217-2220
5. Hasegawa M, Jakes R, Crowther RA, et al. Characterization of mAb AP422, a novel phosphorylation-dependent monoclonal antibody against tau protein. FEES Lett 1996;384:25-30
6. Buee-Scherrer V, Buée L, Hof PR, et al. Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism dementia of Guam: immunochemical characterization of tau proteins. Am J Pathol 1995:146:924-932
7. Flament S, Delacourte A, Verny M, et al. Abnormal tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type. Acta Neuropathol 1991;81:591-596
8. Vermersch P, Robitaille Y, Bernier L, et al. Biochemical mapping of neurofibrillary degeneration in a case of progressive supranuclear palsy: evidence for general cortical involvement. Acta Neuropathol 1994:87:572-577
9. Feany MB, Ksiezak-Reding H, Liu WK, et al. Epitope expression and hyperphosphorylation of tau protein in corticobasal degeneration: differentiation from progressive supranuclear palsy. Acta Neuropathol 1995:90:37-43
10. Buée-Scherrer V, Hof PR, Buée L, et al. Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick's disease. Acta Neuropathol 1996:91:351-359
11. Schmidt ML, Huang R, Martin JA, et al. Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHFtau. J Neuropathol Exp Neurol 1996:55:534-539
12. Delacourte A, Robitaille Y, Sergeant N, et al. Spécifie pathological tau protein variants characterize Pick's disease. J Neuropathol Exp Neurol 1996:55:159-168
13. Hof PR, Charpiot A, Delacourte A, et al. Distribution of neurofibrillary tangles and senile plaques in the cerebral cortex in postencephalitic parkinsonism. Neurosci Lett 1992;139:10-14
14. Geddes JF, Hughes AJ, Lees AJ, Daniel SE. Pathological overlap in cases of parkinsonism associated with neurofibrillary tangles. Brain 1993:116:281-302
15. Buée-Scherrer V, Condamines O, Mourton-Gilles C, et al. AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease. Mol Brain=Res 1996:39:79-88
16. Howard RS, Lees AJ. Encephalitis lethargica: a report of four recent cases. Brain 1987:110:19-33
17. Calne DB, Lees AJ. Late progression of postencephalitic Parkinson's syndrome. Can J Neurol Sei 1988;15:135-138
18. Litvan I, Hauw JJ, Bartko JJ, et al. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 1996:55:97-105
19. Lilienfeld DE, Perl DP, Olanow CW. Guam neurodegeneration. In: Calne DB, eds. Neurodegenerative diseases. Philadelphia: WB Saunders, 1994:895-908